reference broth microdilution method (JMI Laboratories)
90
Structured Review
JMI Laboratories
reference broth microdilution method
Reference Broth Microdilution Method, supplied by JMI Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/reference+broth+microdilution+method/reference+broth+microdilution+methods/pmc12024024-264-7-25
Average 90 stars, based on 1 article reviews
Reference Broth Microdilution Method, supplied by JMI Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/reference+broth+microdilution+method/reference+broth+microdilution+methods/pmc12024024-264-7-25
Average 90 stars, based on 1 article reviews
reference broth microdilution method - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: Ceftolozane-tazobactam activity against clinical isolates of Pseudomonas aeruginosa from ICU patients with pneumonia: United States, 2015-2018. Article Snippet: Article Title: Activity of the Novel Aminomethylcycline KBP-7072 and Comparators against 1,057 Geographically Diverse Recent Clinical Isolates from the SENTRY Surveillance Program, 2019 Article Snippet: Article Title: Susceptibility trends of ceftolozane/tazobactam and comparators when tested against U.S. gram-negative bacterial surveillance isolates (2012-2018). Article Snippet: Ceftolozane/tazobactam is an antipseudomonal cephalosporin combined with a b-lactamase inhibitor.. Ceftolozane/tazobactam has been approved in >60 countries for treating complicated urinary tract infections, acute pyelonephritis, complicated intra-abdominal infections (with metronidazole), and hospital-acquired pneumonia, including ventilator-associated pneumonia in adults.. We analyzed susceptibilities for 35,882 gram-negative isolates collected from patients in 35 US medical centers from 2012 to 2018. Article Title: Characterization of Enterobacter cloacae and Citrobacter freundii Species Complex Isolates with Decreased Susceptibility to Cephalosporins from United States Hospitals and Activity of Aztreonam–Avibactam and Comparator Agents (2019–2023) Article Snippet: All isolates were Article Title: Antimicrobial activity of ceftibuten-avibactam against a global collection of Enterobacterales from patients with urinary tract infections (2021) Article Snippet: Article Title: Activity of Ceftolozane-Tazobactam Against Gram-Negative Isolates from Australia and New Zealand as part of the PACTS Surveillance 2016-2018. Article Snippet: Article Title: Comparative activity of newer β-lactam/β-lactamase inhibitor combinations against Pseudomonas aeruginosa isolates from US medical centres (2020-2021). Article Snippet: Antimicrobial susceptibility was evaluated by Article Title: Comparative activity of newer β-lactam/β-lactamase inhibitor combinations against Pseudomonas aeruginosa from patients hospitalized with pneumonia in European medical centers in 2020 Article Snippet: All isolates were susceptibility tested using the |